人类肠道微生物组与人体代谢：对肥胖症和糖尿病的影响。
The human gut microbiome and body metabolism: implications for obesity and diabetes.
机构信息
Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA.
出版信息
Clin Chem. 2013 Apr;59(4):617-28. doi: 10.1373/clinchem.2012.187617. Epub 2013 Feb 11.
Abstract
BACKGROUND
Obesity, metabolic syndrome, and type 2 diabetes are major public health challenges. Recently, interest has surged regarding the possible role of the intestinal microbiota as potential novel contributors to the increased prevalence of these 3 disorders.
CONTENT
Recent advances in microbial DNA sequencing technologies have resulted in the widespread application of whole-genome sequencing technologies for metagenomic DNA analysis of complex ecosystems such as the human gut. Current evidence suggests that the gut microbiota affect nutrient acquisition, energy harvest, and a myriad of host metabolic pathways.
CONCLUSION
Advances in the Human Microbiome Project and human metagenomics research will lead the way toward a greater understanding of the importance and role of the gut microbiome in metabolic disorders such as obesity, metabolic syndrome, and diabetes.
摘要
背景
肥胖症、代谢综合征和 2 型糖尿病是重大的公共健康挑战。最近，人们对肠道微生物组可能作为这三种疾病发病率上升的潜在新因素的作用产生了浓厚的兴趣。
内容
微生物 DNA 测序技术的最新进展使得全基因组测序技术广泛应用于人类肠道等复杂生态系统的宏基因组 DNA 分析。目前的证据表明，肠道微生物组会影响营养物质的获取、能量的收获以及宿主代谢途径的多样性。
结论
人类微生物组计划和人类宏基因组学研究的进展将有助于更好地理解肠道微生物组在肥胖症、代谢综合征和糖尿病等代谢紊乱中的重要性和作用。
相似文献
1
The human gut microbiome and body metabolism: implications for obesity and diabetes.人类肠道微生物组与人体代谢：对肥胖症和糖尿病的影响。
Clin Chem. 2013 Apr;59(4):617-28. doi: 10.1373/clinchem.2012.187617. Epub 2013 Feb 11.
2
[Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].[肠道微生物群的生理模式。肠道菌群失调在肥胖、胰岛素抵抗、糖尿病和代谢综合征中的作用]
Orv Hetil. 2016 Jan 3;157(1):13-22. doi: 10.1556/650.2015.30296.
3
Role of the microbiome in energy regulation and metabolism.微生物组在能量调节和代谢中的作用。
Gastroenterology. 2014 May;146(6):1525-33. doi: 10.1053/j.gastro.2014.02.008. Epub 2014 Feb 19.
4
Obesity, diabetes, and the gut microbiome: an updated review.肥胖、糖尿病与肠道微生物群：最新综述
Expert Rev Gastroenterol Hepatol. 2019 Jan;13(1):3-15. doi: 10.1080/17474124.2019.1543023. Epub 2018 Nov 13.
5
Functional interactions between the gut microbiota and host metabolism.肠道微生物群与宿主代谢的功能相互作用。
Nature. 2012 Sep 13;489(7415):242-9. doi: 10.1038/nature11552.
6
Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded?肥胖、糖尿病与肠道微生物群：卫生假说的扩展？
Diabetes Care. 2010 Oct;33(10):2277-84. doi: 10.2337/dc10-0556.
7
Intestinal MicrobiOMICS to define health and disease in human and mice.肠道微生物组学定义人类和小鼠的健康和疾病。
Curr Pharm Biotechnol. 2012 Apr;13(5):746-58. doi: 10.2174/138920112799857567.
8
Evaluating Causality of Gut Microbiota in Obesity and Diabetes in Humans.评估人体肥胖和糖尿病中肠道微生物组的因果关系。
Endocr Rev. 2018 Apr 1;39(2):133-153. doi: 10.1210/er.2017-00192.
9
Coordinated regulation of the metabolome and lipidome at the host-microbial interface.宿主-微生物界面处代谢组和脂质组的协同调控。
Biochim Biophys Acta. 2010 Mar;1801(3):240-5. doi: 10.1016/j.bbalip.2009.09.009. Epub 2009 Sep 24.
10
Translational research into gut microbiota: new horizons in obesity treatment.肠道微生物群的转化研究：肥胖治疗的新视野。
Arq Bras Endocrinol Metabol. 2009 Mar;53(2):139-44. doi: 10.1590/s0004-27302009000200004.
引用本文的文献
1
A computational framework for inferring species dynamics and interactions with applications in microbiota ecology.一种用于推断物种动态及相互作用的计算框架及其在微生物群落生态学中的应用
NPJ Syst Biol Appl. 2025 Aug 5;11(1):87. doi: 10.1038/s41540-025-00568-0.
2
The influence of high-fat diet and energy-restricted diet on hematopoietic stem cells: mechanisms and implications.高脂饮食和能量限制饮食对造血干细胞的影响：机制与意义
Front Immunol. 2025 May 30;16:1576118. doi: 10.3389/fimmu.2025.1576118. eCollection 2025.
3
Pathogenic profiles and lower respiratory tract microbiota in severe pneumonia patients using metagenomic next-generation sequencing.采用宏基因组二代测序技术分析重症肺炎患者的致病谱及下呼吸道微生物群
Adv Biotechnol (Singap). 2025 Apr 25;3(2):13. doi: 10.1007/s44307-025-00064-w.
4
Impact of Early-Life Microbiota on Immune System Development and Allergic Disorders.早期微生物群对免疫系统发育和过敏性疾病的影响。
Biomedicines. 2025 Jan 7;13(1):121. doi: 10.3390/biomedicines13010121.
5
Influence of gut bacteria on type 2 diabetes: Mechanisms and therapeutic strategy.肠道细菌对2型糖尿病的影响：机制与治疗策略
World J Diabetes. 2025 Jan 15;16(1):100376. doi: 10.4239/wjd.v16.i1.100376.
6
PredCMB: predicting changes in microbial metabolites based on the gene-metabolite network analysis of shotgun metagenome data.PredCMB：基于鸟枪法宏基因组数据的基因-代谢物网络分析预测微生物代谢物的变化
Bioinformatics. 2024 Dec 26;41(1). doi: 10.1093/bioinformatics/btaf020.
7
Micro-DeMix: a mixture beta-multinomial model for investigating the heterogeneity of the stool microbiome compositions.Micro-DeMix：一种用于研究粪便微生物群组成异质性的混合β-多项分布模型。
Bioinformatics. 2024 Nov 28;40(12). doi: 10.1093/bioinformatics/btae667.
8
Gut microbiota composition and type 2 diabetes: Are these subjects linked Together?肠道微生物群组成与2型糖尿病：这些受试者有关联吗？
Heliyon. 2024 Oct 16;10(20):e39464. doi: 10.1016/j.heliyon.2024.e39464. eCollection 2024 Oct 30.
9
Sugar lowering in fermented apple-pear juice orchestrates a promising metabolic answer in the gut microbiome and intestinal integrity.发酵苹果梨汁中的降糖作用在肠道微生物群和肠道完整性方面引发了一个有前景的代谢反应。
Curr Res Food Sci. 2024 Sep 5;9:100833. doi: 10.1016/j.crfs.2024.100833. eCollection 2024.
10
Broadening horizons: intestinal microbiota as a novel biomarker and potential treatment for hypertensive disorders of pregnancy.拓宽视野：肠道微生物群作为妊娠高血压疾病的新型生物标志物和潜在治疗靶点。
Front Cell Infect Microbiol. 2024 Aug 22;14:1446580. doi: 10.3389/fcimb.2024.1446580. eCollection 2024.
本文引用的文献
1
Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation.益生菌对肠道微生物群的影响：肠道免疫调节和神经调节的机制。
Therap Adv Gastroenterol. 2013 Jan;6(1):39-51. doi: 10.1177/1756283X12459294.
2
Antibiotics in early life alter the murine colonic microbiome and adiposity.生命早期使用抗生素会改变小鼠结肠微生物群组成和肥胖。
Nature. 2012 Aug 30;488(7413):621-6. doi: 10.1038/nature11400.
3
Analysis of the gut microbiota in the old order Amish and its relation to the metabolic syndrome.分析旧秩序阿米什人的肠道微生物群及其与代谢综合征的关系。
PLoS One. 2012;7(8):e43052. doi: 10.1371/journal.pone.0043052. Epub 2012 Aug 15.
4
Host responses to the human microbiome.人体微生物组的宿主反应。
Nutr Rev. 2012 Aug;70 Suppl 1:S14-7. doi: 10.1111/j.1753-4887.2012.00496.x.
5
Modulation of gut microbiota by antibiotics improves insulin signalling in high-fat fed mice.抗生素对肠道微生物群的调节作用改善了高脂肪喂养小鼠的胰岛素信号传导。
Diabetologia. 2012 Oct;55(10):2823-2834. doi: 10.1007/s00125-012-2648-4. Epub 2012 Jul 25.
6
Endo-β-N-acetylglucosaminidases from infant gut-associated bifidobacteria release complex N-glycans from human milk glycoproteins.婴儿肠道相关双歧杆菌的内-β-N-乙酰氨基葡萄糖苷酶从人乳糖蛋白中释放复杂的 N-聚糖。
Mol Cell Proteomics. 2012 Sep;11(9):775-85. doi: 10.1074/mcp.M112.018119. Epub 2012 Jun 27.
7
Complex carbohydrate utilization by the healthy human microbiome.健康人体微生物组对复杂碳水化合物的利用。
PLoS One. 2012;7(6):e28742. doi: 10.1371/journal.pone.0028742. Epub 2012 Jun 13.
8
A framework for human microbiome research.人类微生物组研究框架。
Nature. 2012 Jun 13;486(7402):215-21. doi: 10.1038/nature11209.
9
Structure, function and diversity of the healthy human microbiome.健康人体微生物组的结构、功能与多样性。
Nature. 2012 Jun 13;486(7402):207-14. doi: 10.1038/nature11234.
10
Host-gut microbiota metabolic interactions.宿主-肠道微生物群代谢相互作用。
Science. 2012 Jun 8;336(6086):1262-7. doi: 10.1126/science.1223813. Epub 2012 Jun 6.
Zotero 插件